Wilson's disease laboratory findings: Difference between revisions
Jump to navigation
Jump to search
Shyam Patel (talk | contribs) No edit summary |
|||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Template:Wilson's disease}} | {{Template:Wilson's disease}} | ||
{{CMG}}; {{AE}} {{AEL}} | {{CMG}} {{shyam}}; {{AE}} {{AEL}} | ||
== Overview == | == Overview == | ||
Laboratory findings suggestive for Wilson's disease include | Laboratory findings suggestive for Wilson's disease include low [[ceruloplasmin]] level, high [[Copper|serum copper]] concentration and high [[urinary]] excretion of the [[copper]]. | ||
== Laboratory findings== | == Laboratory findings== | ||
| Line 23: | Line 23: | ||
* In patients suspected with Wilson's disease, the [[urine]] should be collected for 24 hours in order to be examined for the [[copper]] concentration. | * In patients suspected with Wilson's disease, the [[urine]] should be collected for 24 hours in order to be examined for the [[copper]] concentration. | ||
* Copper level in urine more than 100 μg/24h is suggestive for Wilson's disease. However, it is not specific for Wilson's disease and may be elevated in other diseases as [[autoimmune hepatitis]] and [[cholestasis]]. | * Copper level in urine more than 100 μg/24h is suggestive for Wilson's disease. However, it is not specific for Wilson's disease and may be elevated in other diseases as [[autoimmune hepatitis]] and [[cholestasis]]. | ||
=== Liver function testing === | |||
* In patients with Wilson's disease, liver function testing will be abnormal. This includes AST, ALT, total bilirubin, and alkaline phosphatase. | |||
== References == | == References == | ||
| Line 28: | Line 31: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Gastroenterology]] | |||
[[Category:Hematology]] | |||
[[Category:Medicine]] | |||
[[Category:Up-To-Date]] | |||
Latest revision as of 18:42, 1 January 2019
|
Wilson's disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Wilson's disease laboratory findings On the Web |
|
American Roentgen Ray Society Images of Wilson's disease laboratory findings |
|
Risk calculators and risk factors for Wilson's disease laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [3]
Overview
Laboratory findings suggestive for Wilson's disease include low ceruloplasmin level, high serum copper concentration and high urinary excretion of the copper.
Laboratory findings
- Laboratory tests are important in cases presenting with impaired liver functions and neurological impairment which increase suspicion against Wilson's disease.
- Liver function tests show nonspecific increase of the liver enzymes aspartate transaminase and alanine transaminase. The bilirubin is elevated as well.
- The following laboratory test are recommended to diagnose Wilson's disease:[1][2]
- Ceruloplasmin level
- Serum copper concentration
- Urinary excretion of the copper (24hr monitoring)
Ceruloplasmin level
- Most of the patients with Wilson's disease will show a low serum level of ceruloplasmin (less than 20mg/dl). However, low ceruloplasmin level only is not sufficient for provisional diagnosis of Wilson's disease.
- Low ceruloplasmin level in patients whose examination shows Kayser-Fleischer ring and neurologic manifestations is diagnostic for Wilson's disease.
Serum copper concentration
- Patients with Wilson's disease will have high level of total body concentration of the copper regardless the copper overload.
Urinary excretion of the copper
- In patients suspected with Wilson's disease, the urine should be collected for 24 hours in order to be examined for the copper concentration.
- Copper level in urine more than 100 μg/24h is suggestive for Wilson's disease. However, it is not specific for Wilson's disease and may be elevated in other diseases as autoimmune hepatitis and cholestasis.
Liver function testing
- In patients with Wilson's disease, liver function testing will be abnormal. This includes AST, ALT, total bilirubin, and alkaline phosphatase.
References
- ↑ Roberts EA, Schilsky ML, Division of Gastroenterology and Nutrition, Hospital for Sick Children, Toronto, Ontario, Canada (2003). "A practice guideline on Wilson disease". Hepatology. 37 (6): 1475–92. doi:10.1053/jhep.2003.50252. PMID 12774027.
- ↑ Harris ZL, Takahashi Y, Miyajima H, Serizawa M, MacGillivray RT, Gitlin JD (1995). "Aceruloplasminemia: molecular characterization of this disorder of iron metabolism". Proc Natl Acad Sci U S A. 92 (7): 2539–43. PMC 42253. PMID 7708681.